Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
John Anthony DiBella II, serving as Chief Revenue Officer for Simulations Plus, Inc. (NASDAQ: SLP), disposed of 1,000 shares of the company's common stock on July 6, 2026. The transaction totaled $18,360 and was executed through multiple sales priced between $18.34 and $18.39 per share. The sale was conducted automatically under a Rule 10b5-1 tradi…
Larimar Therapeutics, Inc. (NASDAQ: LRMR) director Hamilton Thomas Edward acquired 50,000 shares on July 6, 2026, totaling $166,890. The acquisition brings his direct holdings to 714,798 shares, with an additional 159,433 shares held indirectly through Post Edison, LLC. The transaction occurred at a weighted average price of $3.3378 per share, with…
Monster Beverage Corporation's Board of Directors declared a 2-for-1 stock split to be effected as a 100% stock dividend, rewarding shareholders with additional shares and increasing stock liquidity. The split will be distributed to shareholders of record on July 24, 2026, with shares trading at the adjusted price starting August 11, 2026.
National Bank Holdings Corporation announced it will report its Q2 2026 financial results on July 21, 2026, followed by a management conference call on July 22. The company operates a network of over 90 banking centers across multiple states, providing banking, mortgage, trust, and wealth management services within its core footprint. The announcem…
Ampco-Pittsburgh reported a 32% year-over-year increase in customer order activity for the first six months of 2026, lifting after-hours trading as investors reacted to broad-based demand gains across its Forged and Cast Engineered Products and Air and Liquid Processing segments and a healthy backlog.
Diana Shipping Inc., a major shareholder of Genco Shipping & Trading, has publicly criticized the Genco board for resisting its negotiated acquisition proposal despite a premium tender offer of $27.34 per share (cash plus shares). Diana asserts that the Genco board's continued maintenance of a poison pill and refusal to negotiate is detrimental to …
Morgan Stanley has designated UnitedHealth Group as its leading stock pick in the managed care sector heading into the second-quarter earnings cycle. The bank raised its price target to $468 and forecasts that UnitedHealth will report second-quarter EPS about $0.10 above consensus, driven by improving utilization trends and strong performance at Op…
Martina M. Flammer, Chief Medical Officer at Insmed Incorporated (NASDAQ: INSM), executed a series of stock transactions on July 6, 2026, selling approximately $1.35 million worth of company shares. The sales were conducted under a pre-arranged 10b5-1 trading plan adopted in February 2025. Concurrently, Dr. Flammer exercised stock options to acquir…
Horizon Kinetics Asset Management LLC has acquired an additional share of Texas Pacific Land Corp (NYSE:TPL) common stock, bringing its direct holdings to 3,263,670 shares. The transaction follows a period of robust financial performance for TPL, which recently reported first-quarter 2026 results that exceeded analyst expectations for both earnings…
Benjamin Thomas Tschirhart, Senior Vice President and Head of Engineered Solutions at AerSale Corp (NASDAQ: ASLE), executed a sale of 77 shares on July 6, 2026. This transaction, valued at $505, was a mandatory sell-to-cover action tied to tax withholding requirements for the vesting of 310 restricted stock units. The sale occurred under a Rule 10b…
Candel Therapeutics announced the grant of inducement stock options to Mark Sims, its new Chief Commercial Officer, as part of his employment agreement. The options cover 285,000 shares at the current market price and will vest over four years. This grant aims to incentivize leadership as the company advances its clinical-stage immunotherapy progra…
ThredUp, a leading online resale platform for apparel, shoes, and accessories, will report its second quarter 2026 financial results after U.S. market close on August 5, 2026, followed by a conference call and live webcast. The company emphasizes its role in transforming the resale market with proprietary technology and a mission-driven approach to…
Byrna Technologies Inc., a Nasdaq-listed personal defense technology company, announced a definitive agreement to acquire substantially all assets of HERO Defense Systems. The acquisition will expand Byrna's product portfolio to include HERO's compact and accessible less-lethal personal defense devices, creating new entry points for consumers inter…
Calidi Biotherapeutics announced inducement non-qualified stock options for Sandra Gurrola, newly appointed VP Finance, Controller. The options total 100,000 shares at an exercise price of $0.15, reflecting the closing price on the grant date, and vest over four years. The company continues development of its RedTail platform targeting metastatic c…
Vaxcyte, Inc., a clinical-stage US vaccine company, announced its participation in upcoming investor conferences where it will present its pipeline of advanced vaccine candidates. Their lead candidates, VAX-31 and VAX-24, target broad protection against invasive pneumococcal disease, with additional vaccines in development including VAX-A1 for Grou…
Astera Labs, a Nasdaq-listed company specializing in semiconductor-based connectivity solutions for AI infrastructure, will release its Q2 2026 financial results after market close on August 4, 2026. A conference call with executives will follow to discuss the results.
Locafy Limited, a SaaS company specializing in location-based SEO and AEO solutions, announced it received a Nasdaq notice for delayed filing of required financial documents but has since furnished the documents and regained compliance. The incident did not affect its listing or trading status on Nasdaq.
BrightSpring Health Services, Inc. plans to release its second quarter 2026 financial results on July 31, 2026, followed by a conference call. The company provides home- and community-based health services across the U.S., serving over 475,000 clients daily with a focus on integrated care and clinical solutions.
Beacon Financial Corporation, a regional bank holding company based in Boston serving the Northeast, will report its second quarter 2026 earnings following market close on July 29, 2026. Management will host a conference call on July 30 to discuss the results. The company provides a range of banking services including commercial, retail, SBA lendin…
Bleichroeder Acquisition Corp. III completed its initial public offering of 34.5 million units at $10 per unit, raising $345 million. The company is a blank check SPAC focused on acquiring North American and European businesses in disruptive growth sectors, especially those undergoing technological transformation. Units began trading on Nasdaq unde…
Latham Group, Inc., the leading designer and manufacturer of in-ground residential swimming pools in North America, Australia, and New Zealand, will release its second quarter 2026 financial results on August 4, 2026, after the U.S. market close. The company will hold a conference call to discuss results the same day.
Nasdaq announced its trading volumes for June 2026, quarterly volumes, estimated revenue capture, number of listings, and index statistics for the second quarter ended June 30, 2026. This data is available on Nasdaq's Investor Relations website.
The Board of Directors of Destination XL Group, Inc. (NASDAQ: DXLG) unanimously recommends shareholders reject Zodiac Partners II's revised unsolicited tender offer of $0.84 per share. The Board considers the offer undervalued and opportunistic amid current market conditions, emphasizing commitment to maximizing shareholder value.
Tarsus Pharmaceuticals has acquired clinical-stage iRenix Medical, gaining the investigational ocular antiseptic IRX-101, which demonstrated positive Phase 2b/3 results in reducing post-procedural pain and corneal toxicity in patients receiving intravitreal therapy. The acquisition strengthens Tarsus's leadership in innovative eye care, providing a…
Barfresh Food Group's CEO Riccardo Delle Coste will participate in Maxim Group's virtual Health, Wellness & Longevity conference, discussing innovations in the beverage industry, including wellness trends and emerging ingredients.
